SREBF1 and hyperinsulinism: Insulin resistance or hyperinsulinemia drives de novo lipogenesis by increasing the production and activation of SREBP-1c and carbohydrate regulatory element binding protein (ChREBP), and enhancing acetyl CoA carboxylase (ACC) activity, further increasing hepatic lipid accumulation [56].